nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCB1—melanoma	0.223	1	CbGaD
Amprenavir—ABCC1—Vemurafenib—melanoma	0.222	0.326	CbGbCtD
Amprenavir—ABCC1—Dactinomycin—melanoma	0.147	0.217	CbGbCtD
Amprenavir—ABCC1—Docetaxel—melanoma	0.0761	0.112	CbGbCtD
Amprenavir—CYP3A4—Temozolomide—melanoma	0.0585	0.0861	CbGbCtD
Amprenavir—CYP2D6—Vemurafenib—melanoma	0.0504	0.0742	CbGbCtD
Amprenavir—ABCB1—Dactinomycin—melanoma	0.0356	0.0523	CbGbCtD
Amprenavir—CYP3A4—Vemurafenib—melanoma	0.0321	0.0472	CbGbCtD
Amprenavir—CYP3A5—Docetaxel—melanoma	0.0282	0.0415	CbGbCtD
Amprenavir—ABCB1—Docetaxel—melanoma	0.0184	0.027	CbGbCtD
Amprenavir—CYP3A4—Docetaxel—melanoma	0.011	0.0162	CbGbCtD
Amprenavir—Opportunistic infection—Temozolomide—melanoma	0.0026	0.0385	CcSEcCtD
Amprenavir—Transaminases increased—Carmustine—melanoma	0.00178	0.0264	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Temozolomide—melanoma	0.00115	0.017	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00114	0.0168	CcSEcCtD
Amprenavir—Connective tissue disorder—Vemurafenib—melanoma	0.00101	0.015	CcSEcCtD
Amprenavir—Erythema multiforme—Vemurafenib—melanoma	0.000974	0.0144	CcSEcCtD
Amprenavir—Cardiac disorder—Vemurafenib—melanoma	0.000956	0.0141	CcSEcCtD
Amprenavir—Diabetes mellitus—Carmustine—melanoma	0.000906	0.0134	CcSEcCtD
Amprenavir—Malnutrition—Vemurafenib—melanoma	0.000897	0.0133	CcSEcCtD
Amprenavir—Liver function test abnormal—Dactinomycin—melanoma	0.000777	0.0115	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Docetaxel—melanoma	0.000767	0.0113	CcSEcCtD
Amprenavir—Myalgia—Vemurafenib—melanoma	0.000764	0.0113	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000758	0.0112	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000758	0.0112	CcSEcCtD
Amprenavir—Liver function test abnormal—Carmustine—melanoma	0.000727	0.0108	CcSEcCtD
Amprenavir—Inflammation—Docetaxel—melanoma	0.000719	0.0106	CcSEcCtD
Amprenavir—Nervous system disorder—Vemurafenib—melanoma	0.000718	0.0106	CcSEcCtD
Amprenavir—Skin disorder—Vemurafenib—melanoma	0.000711	0.0105	CcSEcCtD
Amprenavir—Acute coronary syndrome—Bleomycin—melanoma	0.000685	0.0101	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000685	0.0101	CcSEcCtD
Amprenavir—Myocardial infarction—Bleomycin—melanoma	0.000682	0.0101	CcSEcCtD
Amprenavir—Neutropenia—Dactinomycin—melanoma	0.00068	0.0101	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Temozolomide—melanoma	0.000671	0.00992	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000667	0.00986	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000643	0.00951	CcSEcCtD
Amprenavir—Neutropenia—Carmustine—melanoma	0.000637	0.00941	CcSEcCtD
Amprenavir—Decreased appetite—Vemurafenib—melanoma	0.000636	0.00941	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Vemurafenib—melanoma	0.000632	0.00934	CcSEcCtD
Amprenavir—Fatigue—Vemurafenib—melanoma	0.000631	0.00933	CcSEcCtD
Amprenavir—Neutropenia—Temozolomide—melanoma	0.000615	0.00909	CcSEcCtD
Amprenavir—Hyperglycaemia—Carmustine—melanoma	0.000614	0.00908	CcSEcCtD
Amprenavir—Depression—Carmustine—melanoma	0.000605	0.00895	CcSEcCtD
Amprenavir—Hyperglycaemia—Temozolomide—melanoma	0.000593	0.00877	CcSEcCtD
Amprenavir—Depression—Temozolomide—melanoma	0.000585	0.00865	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000582	0.0086	CcSEcCtD
Amprenavir—Hepatobiliary disease—Temozolomide—melanoma	0.000555	0.0082	CcSEcCtD
Amprenavir—Erythema multiforme—Dactinomycin—melanoma	0.00055	0.00814	CcSEcCtD
Amprenavir—Connective tissue disorder—Carmustine—melanoma	0.000535	0.00792	CcSEcCtD
Amprenavir—Asthenia—Vemurafenib—melanoma	0.000525	0.00776	CcSEcCtD
Amprenavir—Pruritus—Vemurafenib—melanoma	0.000518	0.00766	CcSEcCtD
Amprenavir—Connective tissue disorder—Temozolomide—melanoma	0.000517	0.00765	CcSEcCtD
Amprenavir—Diarrhoea—Vemurafenib—melanoma	0.000501	0.0074	CcSEcCtD
Amprenavir—Erythema multiforme—Temozolomide—melanoma	0.000498	0.00736	CcSEcCtD
Amprenavir—Cardiac disorder—Temozolomide—melanoma	0.000489	0.00722	CcSEcCtD
Amprenavir—Mental disorder—Carmustine—melanoma	0.000477	0.00706	CcSEcCtD
Amprenavir—Malnutrition—Carmustine—melanoma	0.000474	0.00701	CcSEcCtD
Amprenavir—Liver function test abnormal—Docetaxel—melanoma	0.000467	0.00691	CcSEcCtD
Amprenavir—Vomiting—Vemurafenib—melanoma	0.000465	0.00688	CcSEcCtD
Amprenavir—Myalgia—Bleomycin—melanoma	0.000463	0.00684	CcSEcCtD
Amprenavir—Rash—Vemurafenib—melanoma	0.000462	0.00682	CcSEcCtD
Amprenavir—Mental disorder—Temozolomide—melanoma	0.000461	0.00682	CcSEcCtD
Amprenavir—Dermatitis—Vemurafenib—melanoma	0.000461	0.00682	CcSEcCtD
Amprenavir—Headache—Vemurafenib—melanoma	0.000459	0.00678	CcSEcCtD
Amprenavir—Malnutrition—Temozolomide—melanoma	0.000458	0.00678	CcSEcCtD
Amprenavir—Discomfort—Bleomycin—melanoma	0.000457	0.00676	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000456	0.00674	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Docetaxel—melanoma	0.000446	0.0066	CcSEcCtD
Amprenavir—Tremor—Carmustine—melanoma	0.000444	0.00657	CcSEcCtD
Amprenavir—Nausea—Vemurafenib—melanoma	0.000435	0.00643	CcSEcCtD
Amprenavir—Myalgia—Dactinomycin—melanoma	0.000431	0.00638	CcSEcCtD
Amprenavir—Tremor—Temozolomide—melanoma	0.000429	0.00635	CcSEcCtD
Amprenavir—Discomfort—Dactinomycin—melanoma	0.000426	0.0063	CcSEcCtD
Amprenavir—Anorexia—Bleomycin—melanoma	0.000423	0.00625	CcSEcCtD
Amprenavir—Angioedema—Temozolomide—melanoma	0.000419	0.00619	CcSEcCtD
Amprenavir—Neutropenia—Docetaxel—melanoma	0.000409	0.00605	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Bleomycin—melanoma	0.000404	0.00597	CcSEcCtD
Amprenavir—Myalgia—Carmustine—melanoma	0.000404	0.00597	CcSEcCtD
Amprenavir—Paraesthesia—Bleomycin—melanoma	0.000398	0.00589	CcSEcCtD
Amprenavir—Anorexia—Dactinomycin—melanoma	0.000394	0.00583	CcSEcCtD
Amprenavir—Myalgia—Temozolomide—melanoma	0.00039	0.00577	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000388	0.00573	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000387	0.00572	CcSEcCtD
Amprenavir—Discomfort—Temozolomide—melanoma	0.000386	0.0057	CcSEcCtD
Amprenavir—Decreased appetite—Bleomycin—melanoma	0.000386	0.0057	CcSEcCtD
Amprenavir—Acute coronary syndrome—Docetaxel—melanoma	0.000385	0.00568	CcSEcCtD
Amprenavir—Myocardial infarction—Docetaxel—melanoma	0.000382	0.00565	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000377	0.00557	CcSEcCtD
Amprenavir—Anorexia—Carmustine—melanoma	0.000369	0.00546	CcSEcCtD
Amprenavir—Hepatobiliary disease—Docetaxel—melanoma	0.000369	0.00545	CcSEcCtD
Amprenavir—Nervous system disorder—Temozolomide—melanoma	0.000367	0.00542	CcSEcCtD
Amprenavir—Skin disorder—Temozolomide—melanoma	0.000363	0.00537	CcSEcCtD
Amprenavir—Decreased appetite—Dactinomycin—melanoma	0.00036	0.00532	CcSEcCtD
Amprenavir—Fatigue—Dactinomycin—melanoma	0.000357	0.00527	CcSEcCtD
Amprenavir—Anorexia—Temozolomide—melanoma	0.000357	0.00527	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Carmustine—melanoma	0.000353	0.00521	CcSEcCtD
Amprenavir—Paraesthesia—Carmustine—melanoma	0.000348	0.00514	CcSEcCtD
Amprenavir—Connective tissue disorder—Docetaxel—melanoma	0.000344	0.00509	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Temozolomide—melanoma	0.000341	0.00504	CcSEcCtD
Amprenavir—Gastrointestinal pain—Dactinomycin—melanoma	0.000338	0.005	CcSEcCtD
Amprenavir—Decreased appetite—Carmustine—melanoma	0.000337	0.00498	CcSEcCtD
Amprenavir—Paraesthesia—Temozolomide—melanoma	0.000336	0.00497	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Carmustine—melanoma	0.000334	0.00494	CcSEcCtD
Amprenavir—Erythema multiforme—Docetaxel—melanoma	0.000331	0.00489	CcSEcCtD
Amprenavir—Abdominal pain—Dactinomycin—melanoma	0.000327	0.00483	CcSEcCtD
Amprenavir—Decreased appetite—Temozolomide—melanoma	0.000325	0.00481	CcSEcCtD
Amprenavir—Cardiac disorder—Docetaxel—melanoma	0.000325	0.0048	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Temozolomide—melanoma	0.000323	0.00477	CcSEcCtD
Amprenavir—Fatigue—Temozolomide—melanoma	0.000323	0.00477	CcSEcCtD
Amprenavir—Asthenia—Bleomycin—melanoma	0.000318	0.0047	CcSEcCtD
Amprenavir—Gastrointestinal pain—Carmustine—melanoma	0.000317	0.00468	CcSEcCtD
Amprenavir—Pruritus—Bleomycin—melanoma	0.000314	0.00464	CcSEcCtD
Amprenavir—Mental disorder—Docetaxel—melanoma	0.000307	0.00454	CcSEcCtD
Amprenavir—Abdominal pain—Carmustine—melanoma	0.000306	0.00452	CcSEcCtD
Amprenavir—Gastrointestinal pain—Temozolomide—melanoma	0.000306	0.00452	CcSEcCtD
Amprenavir—Malnutrition—Docetaxel—melanoma	0.000305	0.00451	CcSEcCtD
Amprenavir—Asthenia—Dactinomycin—melanoma	0.000297	0.00439	CcSEcCtD
Amprenavir—Abdominal pain—Temozolomide—melanoma	0.000296	0.00437	CcSEcCtD
Amprenavir—Diarrhoea—Dactinomycin—melanoma	0.000283	0.00418	CcSEcCtD
Amprenavir—Vomiting—Bleomycin—melanoma	0.000282	0.00417	CcSEcCtD
Amprenavir—Rash—Bleomycin—melanoma	0.00028	0.00413	CcSEcCtD
Amprenavir—Dermatitis—Bleomycin—melanoma	0.000279	0.00413	CcSEcCtD
Amprenavir—Asthenia—Carmustine—melanoma	0.000278	0.00411	CcSEcCtD
Amprenavir—Asthenia—Temozolomide—melanoma	0.000268	0.00397	CcSEcCtD
Amprenavir—Diarrhoea—Carmustine—melanoma	0.000265	0.00392	CcSEcCtD
Amprenavir—Pruritus—Temozolomide—melanoma	0.000265	0.00391	CcSEcCtD
Amprenavir—Nausea—Bleomycin—melanoma	0.000263	0.00389	CcSEcCtD
Amprenavir—Vomiting—Dactinomycin—melanoma	0.000263	0.00389	CcSEcCtD
Amprenavir—Rash—Dactinomycin—melanoma	0.000261	0.00386	CcSEcCtD
Amprenavir—Myalgia—Docetaxel—melanoma	0.00026	0.00384	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000258	0.00381	CcSEcCtD
Amprenavir—Diarrhoea—Temozolomide—melanoma	0.000256	0.00378	CcSEcCtD
Amprenavir—Vomiting—Carmustine—melanoma	0.000246	0.00364	CcSEcCtD
Amprenavir—Nausea—Dactinomycin—melanoma	0.000246	0.00363	CcSEcCtD
Amprenavir—Rash—Carmustine—melanoma	0.000244	0.00361	CcSEcCtD
Amprenavir—Nervous system disorder—Docetaxel—melanoma	0.000244	0.00361	CcSEcCtD
Amprenavir—Dermatitis—Carmustine—melanoma	0.000244	0.00361	CcSEcCtD
Amprenavir—Headache—Carmustine—melanoma	0.000243	0.00359	CcSEcCtD
Amprenavir—Skin disorder—Docetaxel—melanoma	0.000242	0.00357	CcSEcCtD
Amprenavir—Vomiting—Temozolomide—melanoma	0.000238	0.00352	CcSEcCtD
Amprenavir—Anorexia—Docetaxel—melanoma	0.000237	0.00351	CcSEcCtD
Amprenavir—Rash—Temozolomide—melanoma	0.000236	0.00349	CcSEcCtD
Amprenavir—Dermatitis—Temozolomide—melanoma	0.000236	0.00348	CcSEcCtD
Amprenavir—Headache—Temozolomide—melanoma	0.000234	0.00346	CcSEcCtD
Amprenavir—Nausea—Carmustine—melanoma	0.00023	0.0034	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Docetaxel—melanoma	0.000227	0.00335	CcSEcCtD
Amprenavir—Paraesthesia—Docetaxel—melanoma	0.000223	0.0033	CcSEcCtD
Amprenavir—Nausea—Temozolomide—melanoma	0.000222	0.00329	CcSEcCtD
Amprenavir—Decreased appetite—Docetaxel—melanoma	0.000216	0.0032	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Docetaxel—melanoma	0.000215	0.00318	CcSEcCtD
Amprenavir—Fatigue—Docetaxel—melanoma	0.000214	0.00317	CcSEcCtD
Amprenavir—Gastrointestinal pain—Docetaxel—melanoma	0.000203	0.00301	CcSEcCtD
Amprenavir—Abdominal pain—Docetaxel—melanoma	0.000197	0.00291	CcSEcCtD
Amprenavir—Asthenia—Docetaxel—melanoma	0.000178	0.00264	CcSEcCtD
Amprenavir—Pruritus—Docetaxel—melanoma	0.000176	0.0026	CcSEcCtD
Amprenavir—Diarrhoea—Docetaxel—melanoma	0.00017	0.00252	CcSEcCtD
Amprenavir—Vomiting—Docetaxel—melanoma	0.000158	0.00234	CcSEcCtD
Amprenavir—Rash—Docetaxel—melanoma	0.000157	0.00232	CcSEcCtD
Amprenavir—Dermatitis—Docetaxel—melanoma	0.000157	0.00232	CcSEcCtD
Amprenavir—Headache—Docetaxel—melanoma	0.000156	0.0023	CcSEcCtD
Amprenavir—Nausea—Docetaxel—melanoma	0.000148	0.00218	CcSEcCtD
Amprenavir—CYP2C9—Metabolism—GPAM—melanoma	9.58e-06	0.000326	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	9.56e-06	0.000326	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	9.56e-06	0.000326	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HIF1A—melanoma	9.41e-06	0.00032	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	9.1e-06	0.00031	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	9.03e-06	0.000308	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—VCAN—melanoma	8.99e-06	0.000306	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP17A1—melanoma	8.96e-06	0.000305	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PLA2G6—melanoma	8.93e-06	0.000304	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PRKCA—melanoma	8.86e-06	0.000302	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ERCC2—melanoma	8.79e-06	0.000299	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP17A1—melanoma	8.76e-06	0.000298	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PLA2G6—melanoma	8.72e-06	0.000297	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PLCB4—melanoma	8.61e-06	0.000293	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NOS2—melanoma	8.56e-06	0.000292	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.51e-06	0.00029	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NOTCH1—melanoma	8.48e-06	0.000289	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GNA11—melanoma	8.46e-06	0.000288	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CD80—melanoma	8.3e-06	0.000283	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	8.29e-06	0.000283	CbGpPWpGaD
Amprenavir—ABCC1—Disease—APC—melanoma	8.29e-06	0.000282	CbGpPWpGaD
Amprenavir—ABCC1—Disease—KIT—melanoma	8.29e-06	0.000282	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—FASN—melanoma	8.28e-06	0.000282	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GNA11—melanoma	8.27e-06	0.000282	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PLA2G6—melanoma	8.22e-06	0.00028	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.21e-06	0.00028	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGF—melanoma	8.19e-06	0.000279	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PLA2G6—melanoma	8.15e-06	0.000278	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—SLC5A5—melanoma	8.15e-06	0.000277	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC6A11—melanoma	8.09e-06	0.000276	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIP4K2A—melanoma	8.09e-06	0.000276	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—FASN—melanoma	8.09e-06	0.000276	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—VCAN—melanoma	8.03e-06	0.000273	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	8.02e-06	0.000273	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—SLC5A5—melanoma	7.96e-06	0.000271	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MTAP—melanoma	7.87e-06	0.000268	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—GNAQ—melanoma	7.87e-06	0.000268	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CD44—melanoma	7.87e-06	0.000268	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—VCAN—melanoma	7.83e-06	0.000267	CbGpPWpGaD
Amprenavir—ABCC1—Disease—BRAF—melanoma	7.79e-06	0.000265	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CD44—melanoma	7.69e-06	0.000262	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GNAQ—melanoma	7.69e-06	0.000262	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.6e-06	0.000259	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP17A1—melanoma	7.59e-06	0.000258	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CYP1B1—melanoma	7.54e-06	0.000257	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.48e-06	0.000255	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	7.39e-06	0.000252	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—VCAN—melanoma	7.38e-06	0.000251	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP1B1—melanoma	7.37e-06	0.000251	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MAP2K1—melanoma	7.33e-06	0.00025	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.33e-06	0.00025	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—VCAN—melanoma	7.32e-06	0.000249	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CD—melanoma	7.29e-06	0.000248	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.28e-06	0.000248	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GNA11—melanoma	7.16e-06	0.000244	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PHGDH—melanoma	7.02e-06	0.000239	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—LUM—melanoma	7.02e-06	0.000239	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—FASN—melanoma	7.01e-06	0.000239	CbGpPWpGaD
Amprenavir—ABCC1—Disease—FGF2—melanoma	6.98e-06	0.000238	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CG—melanoma	6.94e-06	0.000236	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.93e-06	0.000236	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—SLC5A5—melanoma	6.9e-06	0.000235	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HPSE—melanoma	6.88e-06	0.000234	CbGpPWpGaD
Amprenavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.78e-06	0.000231	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP17A1—melanoma	6.77e-06	0.000231	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CUBN—melanoma	6.76e-06	0.00023	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PPARG—melanoma	6.7e-06	0.000228	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.69e-06	0.000228	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.68e-06	0.000228	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GNAQ—melanoma	6.66e-06	0.000227	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CD44—melanoma	6.66e-06	0.000227	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP17A1—melanoma	6.61e-06	0.000225	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	6.59e-06	0.000225	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MDM2—melanoma	6.53e-06	0.000222	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SDHD—melanoma	6.52e-06	0.000222	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—BSG—melanoma	6.52e-06	0.000222	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CSPG4—melanoma	6.52e-06	0.000222	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.52e-06	0.000222	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.46e-06	0.00022	CbGpPWpGaD
Amprenavir—ABCC1—Disease—ERBB2—melanoma	6.44e-06	0.000219	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GNA11—melanoma	6.39e-06	0.000218	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP1B1—melanoma	6.39e-06	0.000218	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CB—melanoma	6.35e-06	0.000216	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CD4—melanoma	6.34e-06	0.000216	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPAM—melanoma	6.32e-06	0.000215	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTGS2—melanoma	6.29e-06	0.000214	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—FASN—melanoma	6.26e-06	0.000213	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GNA11—melanoma	6.24e-06	0.000213	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP17A1—melanoma	6.23e-06	0.000212	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ABCB1—melanoma	6.21e-06	0.000212	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP17A1—melanoma	6.17e-06	0.00021	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—SLC5A5—melanoma	6.16e-06	0.00021	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	6.12e-06	0.000208	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—FASN—melanoma	6.11e-06	0.000208	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CD—melanoma	6.1e-06	0.000208	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.09e-06	0.000207	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ABCB1—melanoma	6.07e-06	0.000207	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—ALB—melanoma	6.02e-06	0.000205	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	6.01e-06	0.000205	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—SLC5A5—melanoma	6.01e-06	0.000205	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN1B—melanoma	5.96e-06	0.000203	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GNAQ—melanoma	5.94e-06	0.000203	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CD44—melanoma	5.94e-06	0.000203	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GNA11—melanoma	5.88e-06	0.0002	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GNA11—melanoma	5.83e-06	0.000199	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.82e-06	0.000198	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GNAQ—melanoma	5.8e-06	0.000198	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CD44—melanoma	5.8e-06	0.000198	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.77e-06	0.000196	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—FASN—melanoma	5.76e-06	0.000196	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PRKCA—melanoma	5.72e-06	0.000195	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—FASN—melanoma	5.71e-06	0.000194	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP1B1—melanoma	5.7e-06	0.000194	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ERCC2—melanoma	5.67e-06	0.000193	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SLC5A5—melanoma	5.66e-06	0.000193	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.64e-06	0.000192	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CTNNB1—melanoma	5.63e-06	0.000192	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SLC5A5—melanoma	5.61e-06	0.000191	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PRKCA—melanoma	5.59e-06	0.00019	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP1B1—melanoma	5.56e-06	0.00019	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ERCC2—melanoma	5.54e-06	0.000189	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN1A—melanoma	5.5e-06	0.000187	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTEN—melanoma	5.49e-06	0.000187	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GNAQ—melanoma	5.47e-06	0.000186	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CD44—melanoma	5.47e-06	0.000186	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GNAQ—melanoma	5.42e-06	0.000185	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CD44—melanoma	5.42e-06	0.000185	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PLA2G6—melanoma	5.37e-06	0.000183	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CB—melanoma	5.32e-06	0.000181	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.31e-06	0.000181	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—melanoma	5.27e-06	0.00018	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.26e-06	0.000179	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ABCB1—melanoma	5.26e-06	0.000179	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP1B1—melanoma	5.24e-06	0.000179	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP1B1—melanoma	5.2e-06	0.000177	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.03e-06	0.000171	CbGpPWpGaD
Amprenavir—ABCC1—Disease—STAT3—melanoma	4.91e-06	0.000167	CbGpPWpGaD
Amprenavir—ABCC1—Disease—NRAS—melanoma	4.9e-06	0.000167	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PRKCA—melanoma	4.84e-06	0.000165	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—VCAN—melanoma	4.83e-06	0.000164	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ERCC2—melanoma	4.8e-06	0.000163	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ABCB1—melanoma	4.69e-06	0.00016	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MAPK3—melanoma	4.69e-06	0.00016	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTEN—melanoma	4.6e-06	0.000157	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.59e-06	0.000156	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MYC—melanoma	4.56e-06	0.000155	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CG—melanoma	4.48e-06	0.000153	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MAPK1—melanoma	4.46e-06	0.000152	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGFR—melanoma	4.46e-06	0.000152	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CG—melanoma	4.38e-06	0.000149	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PPARG—melanoma	4.32e-06	0.000147	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PRKCA—melanoma	4.32e-06	0.000147	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ABCB1—melanoma	4.32e-06	0.000147	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ERCC2—melanoma	4.28e-06	0.000146	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ABCB1—melanoma	4.28e-06	0.000146	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PPARG—melanoma	4.22e-06	0.000144	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PRKCA—melanoma	4.22e-06	0.000144	CbGpPWpGaD
Amprenavir—ABCC1—Disease—KRAS—melanoma	4.21e-06	0.000144	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ERCC2—melanoma	4.18e-06	0.000142	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP17A1—melanoma	4.07e-06	0.000139	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.98e-06	0.000135	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PRKCA—melanoma	3.97e-06	0.000135	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ERCC2—melanoma	3.94e-06	0.000134	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PRKCA—melanoma	3.94e-06	0.000134	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CD—melanoma	3.94e-06	0.000134	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ERCC2—melanoma	3.91e-06	0.000133	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ALB—melanoma	3.89e-06	0.000132	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CA—melanoma	3.87e-06	0.000132	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CD—melanoma	3.85e-06	0.000131	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GNA11—melanoma	3.85e-06	0.000131	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ALB—melanoma	3.8e-06	0.000129	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CG—melanoma	3.79e-06	0.000129	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—FASN—melanoma	3.76e-06	0.000128	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC5A5—melanoma	3.7e-06	0.000126	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PPARG—melanoma	3.66e-06	0.000125	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HRAS—melanoma	3.58e-06	0.000122	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GNAQ—melanoma	3.57e-06	0.000122	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CD44—melanoma	3.57e-06	0.000122	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.55e-06	0.000121	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CB—melanoma	3.43e-06	0.000117	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IL6—melanoma	3.43e-06	0.000117	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP1B1—melanoma	3.43e-06	0.000117	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—melanoma	3.4e-06	0.000116	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CG—melanoma	3.38e-06	0.000115	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CB—melanoma	3.35e-06	0.000114	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CD—melanoma	3.33e-06	0.000114	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—melanoma	3.32e-06	0.000113	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CG—melanoma	3.3e-06	0.000112	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ALB—melanoma	3.29e-06	0.000112	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PPARG—melanoma	3.27e-06	0.000111	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CA—melanoma	3.24e-06	0.00011	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.24e-06	0.00011	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PPARG—melanoma	3.19e-06	0.000109	CbGpPWpGaD
Amprenavir—ABCC1—Disease—AKT1—melanoma	3.16e-06	0.000108	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CG—melanoma	3.11e-06	0.000106	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CG—melanoma	3.08e-06	0.000105	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PPARG—melanoma	3e-06	0.000102	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PPARG—melanoma	2.98e-06	0.000101	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CD—melanoma	2.97e-06	0.000101	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTEN—melanoma	2.96e-06	0.000101	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALB—melanoma	2.94e-06	0.0001	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CB—melanoma	2.9e-06	9.89e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CD—melanoma	2.9e-06	9.89e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTEN—melanoma	2.9e-06	9.87e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—melanoma	2.88e-06	9.8e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALB—melanoma	2.87e-06	9.76e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCB1—melanoma	2.82e-06	9.61e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CD—melanoma	2.74e-06	9.32e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CD—melanoma	2.71e-06	9.24e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALB—melanoma	2.7e-06	9.2e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALB—melanoma	2.68e-06	9.12e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—AKT1—melanoma	2.65e-06	9.02e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PRKCA—melanoma	2.6e-06	8.85e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CB—melanoma	2.59e-06	8.83e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ERCC2—melanoma	2.58e-06	8.78e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—melanoma	2.57e-06	8.75e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CB—melanoma	2.53e-06	8.62e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTEN—melanoma	2.51e-06	8.55e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—melanoma	2.51e-06	8.54e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CB—melanoma	2.38e-06	8.12e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CB—melanoma	2.36e-06	8.05e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—melanoma	2.36e-06	8.05e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—melanoma	2.34e-06	7.98e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTEN—melanoma	2.24e-06	7.63e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTEN—melanoma	2.19e-06	7.45e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CA—melanoma	2.09e-06	7.12e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTEN—melanoma	2.06e-06	7.02e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CA—melanoma	2.04e-06	6.96e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTEN—melanoma	2.04e-06	6.96e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CG—melanoma	2.03e-06	6.93e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PPARG—melanoma	1.96e-06	6.69e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CD—melanoma	1.79e-06	6.09e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CA—melanoma	1.77e-06	6.03e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALB—melanoma	1.77e-06	6.01e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—AKT1—melanoma	1.71e-06	5.82e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—AKT1—melanoma	1.67e-06	5.69e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CA—melanoma	1.58e-06	5.38e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CB—melanoma	1.56e-06	5.31e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—melanoma	1.54e-06	5.26e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CA—melanoma	1.54e-06	5.25e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CA—melanoma	1.45e-06	4.95e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—AKT1—melanoma	1.45e-06	4.93e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CA—melanoma	1.44e-06	4.91e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTEN—melanoma	1.35e-06	4.59e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AKT1—melanoma	1.29e-06	4.4e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AKT1—melanoma	1.26e-06	4.29e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AKT1—melanoma	1.19e-06	4.04e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AKT1—melanoma	1.18e-06	4.01e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CA—melanoma	9.5e-07	3.24e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AKT1—melanoma	7.76e-07	2.64e-05	CbGpPWpGaD
